EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin

Konrad Rejdak, Halina Sienkiewicz-Jarosz, Przemyslaw Bienkowski, Anton Alvarez iD

Medicinal Research Reviews · 2023-09 · 43 (5) · 1668-1700

DOI: 10.1002/med.21960 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 13.04.2023. Verfasst von Konrad Rejdak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical University of Lublin, Lublin, Poland. Hauptthemen laut MEDLINE: Stroke, Brain Injuries, Traumatic, Dementia, Neuroprotective Agents. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 340 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurotrophic factors (NTFs) are involved in the pathophysiology of neurological disorders such as dementia, stroke and traumatic brain injury (TBI), and constitute molecular targets of high interest for the therapy of these pathologies. In this review we provide an overview of current knowledge of the definition, discovery and mode of action of five NTFs, nerve growth factor, insulin‐like growth factor 1, brain derived NTF, vascular endothelial growth factor and tumor necrosis factor alpha; as well as on their contribution to brain pathology and potential therapeutic use in dementia, stroke and TBI. Within the concept of NTFs in the treatment of these pathologies, we also review the neuropeptide preparation Cerebrolysin, which has been shown to resemble the activities of NTFs and to modulate the expression level of endogenous NTFs. Cerebrolysin has demonstrated beneficial treatment capabilities in vitro and in clinical studies, which are discussed within the context of the biochemistry of NTFs. The review focuses on the interactions of different NTFs, rather than addressing a single NTF, by outlining their signaling network and by reviewing their effect on clinical outcome in prevalent brain pathologies. The effects of the interactions of these NTFs and Cerebrolysin on neuroplasticity, neurogenesis, angiogenesis and inflammation, and their relevance for the treatment of dementia, stroke and TBI are summarized.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeBrain Injuries, TraumaticDementiaNeuroprotective AgentsHumansVascular Endothelial Growth Factor AAmino Acids

Stichwörter der Autor:innen

Cerebrolysindementianeurotrophic factorsstroketraumatic brain injury

Substanzen

Vascular Endothelial Growth Factor ANeuroprotective AgentscerebrolysinAmino Acids

Autor:innen und Institutionen

  • Department of Neurology, Medical University of Lublin, Lublin, Poland.
  • Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.
  • Department of Psychiatry, Warsaw Medical University, Warsaw, Poland.
  • Medinova Institute of Neurosciences, Clinica RehaSalud, Coruña, Spain.

ORCID-Profile: Anton Alvarez

Zitieren

APA

Rejdak, K., Sienkiewicz-Jarosz, H., Bienkowski, P., & Alvarez, A. (2023). Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin. Medicinal Research Reviews, 43(5), 1668-1700. https://doi.org/10.1002/med.21960

Vancouver

Rejdak K, Sienkiewicz-Jarosz H, Bienkowski P, Alvarez A. Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin. Medicinal Research Reviews. 2023;43(5):1668-1700. doi:10.1002/med.21960

BibTeX
@article{Rejdak2023,
  author = {Rejdak, Konrad and Sienkiewicz-Jarosz, Halina and Bienkowski, Przemyslaw and Alvarez, Anton},
  title = {Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin},
  journal = {Medicinal Research Reviews},
  year = {2023},
  volume = {43},
  number = {5},
  pages = {1668--1700},
  doi = {10.1002/med.21960}
}
Kostenlos starten →